TrialInternational journal of clinical oncology2019

Bortezomib-based strategy with autologous stem cell transplantation for newly diagnosed multiple myeloma: a phase II study by the Japan Study Group for Cell Therapy and Transplantation (JSCT-MM12).

Kazutaka Sunami et al.PubMed ↗Publisher ↗

No numbers read from the abstract.